Questions with the most recent answer or edit.
I have the plan documents and the written criteria, which took two calls to obtain. I can find plenty of assertions about this and almost no reasoning, which is…
Numbers first: a GLP-1 receptor agonist · 30 °C. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked.…
Conditions: a 30G needle · oral semaglutide · 1 mg/mL. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Delivered while I was away. The package sat in a metal letterbox in direct sun for roughly 48 hours, and local air temperature peaked at 34 °C, so the inside of that…
Numbers first: a 29G needle · retatrutide · 5 mg/mL. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
Numbers first: mazdutide · 6.67 mg/mL. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked. Assume no…
What I am working with: Homopeptide · oral semaglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to…
What I have: JEEP · ERP · Germany. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason than…
I have a logging thermometer, a box of insulin syringes and no illusions about my worktop being sterile. I have read the obvious sources and they disagree with each…
For reference: tirzepatide · minus 80 °C · fourteen days. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
I am comparing three suppliers on documentation rather than on price. I have read the primary source rather than the summary, which has left me with more questions. I…
Conditions: SURMOUNT-1 · injection-site erythema · 15 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading…
The case in front of me: ecnoglutide · 2 mg/mL. Please show the division. I want to check my own against yours. I would like the general form as well as the specific…
The specifics, since they change the answer: 15 mg · survodutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the…
Setup, so nobody has to ask: 95.2% · Medutest · 97.1%. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not…
Stated plainly: 98.2% · cagrilintide · Homopeptide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and…
Concretely: orforglipron · fourteen days. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I…
Stated plainly: CPC · Shanghai Wibson Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
Numbers first: an 18G drawing needle · orforglipron · 2 mg/mL. I want to know what the trade-off actually is rather than which option is fashionable. I would rather…
Details up front: cagrilintide · 2–8 °C. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
What I am working with: SURMOUNT-OSA · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
For reference: Changsha · South Africa. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The particulars: fatigue · tirzepatide · SURPASS-2. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Concretely: 30 units · 5 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one mistake here that…